ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $166,000 | -20.2% | 11,674 | -8.4% | 0.02% | +72.7% |
| Q1 2018 | $208,000 | -83.3% | 12,746 | -91.4% | 0.01% | -86.4% |
| Q2 2017 | $1,243,000 | +193.9% | 148,485 | +213.9% | 0.08% | +252.2% |
| Q1 2017 | $423,000 | -22.7% | 47,306 | -41.7% | 0.02% | -20.7% |
| Q3 2016 | $547,000 | +257.5% | 81,085 | +123.4% | 0.03% | +314.3% |
| Q4 2015 | $153,000 | -79.7% | 36,293 | -78.0% | 0.01% | -81.1% |
| Q3 2015 | $753,000 | +39.4% | 165,041 | +120.4% | 0.04% | +76.2% |
| Q2 2015 | $540,000 | +120.4% | 74,895 | +125.1% | 0.02% | +110.0% |
| Q1 2015 | $245,000 | +222.4% | 33,278 | +99.1% | 0.01% | +233.3% |
| Q2 2014 | $76,000 | -64.7% | 16,714 | -51.5% | 0.00% | -82.4% |
| Q3 2013 | $215,000 | -36.8% | 34,486 | -53.9% | 0.02% | -57.5% |
| Q2 2013 | $340,000 | – | 74,886 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |